Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonist of the BTLA/HVEM interaction for use in therapy

Antagonist of the BTLA/HVEM interaction for use in therapy

US Patent 10005839 · Granted Jun 26, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payl2025
Antibodies having specificity for nectin-4 and uses thereof2025
Antibodies having specificity for BTN2 and uses thereof2025
Antibodies having specificity for BTN2 and uses thereof2025
BTN3A binding proteins and uses thereof2025
BTN3A binding proteins and uses thereof2025
Anti-nectin-4-antibodies and uses thereof2024
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders2024
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders2024
Chimeric antigen receptor specific for interleukin-23 receptor2024
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders2024
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders2024